Search

Search Results

1. Peritoneal metastases in patients with neuroendocrine neoplasms: a challenging site of metastases with clinical and prognostic implications

   Purpose

   Peritoneal metastases (PM) of neuroendocrine neoplasm (NEN) origin are identified with increasing frequency and exert a significant effect on...

   M. Tsoli, H. Wilson, ... C. Toumpanakis in Journal of Endocrinological Investigation

   Article 07 March 2024
   

2. Port Site Metastases of Carcinoma Endometrium: Case Report and Literature Review

   Introduction

   Carcinoma endometrium with port site metastases usually have poor survival, we present a case of carcinoma endometrium with port site...

   S. Subbiah Shanmugam, Bharani dharan, S. Aravind in Indian Journal of Gynecologic Oncology

   Article 12 May 2023

3. Iodine-125 Brachytherapy for Palliative Treatment of Painful Colorectal Cancer Port-Site Metastases

   Objective

   To summarize the treatment process of a case of Iodine-125 Brachytherapy for Palliative Treatment of Painful Colorectal Cancer Port-Site...

   **aoli Liu, Huimin Yu, ... Hongtao Zhang in Journal of Gastrointestinal Cancer

   Article 27 October 2023
   

4. Prognostic factors among patients with brain metastases from cancer of unknown primary site

   Purpose

   Cancers of an unknown primary site (CUPs) have a dismal prognosis, and the situation is even worse for CUPs patients with brain metastases...

   C. Simões Padilla, V. K. Y. Ho, ... C. Loef in Journal of Neuro-Oncology

   Article 17 August 2022
   

5. Perirenal Fascia — an Uncommon Site of Metastases in Prostate Cancer Detected on ⁶⁸Ga-PSMA-11 PET/CT

   Prostate-specific membrane antigen (PSMA) PET/CT is being increasingly utilized as a hybrid imaging modality for the evaluation of prostate cancer...

   Kunal Ramesh Chandekar, Swayamjeet Satapathy, ... Rakesh Kumar in Nuclear Medicine and Molecular Imaging

   Article 28 April 2023
   

6. Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

   Background

   To evaluate the anatomic site(s) of initial disease progression in patients with castration resistant metastatic prostate cancer (mCRPC) in...

   Kathleen Ruchalski, Hyun J. Kim, ... Jonathan Goldin in Cancer Imaging

   Article Open access 14 July 2022
   

7. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review

   Cancer of unknown primary (CUP) is a well-studied entity with guidelines available for the management of patients with CUP. The peritoneum represents...

   Aditi Bhatt, Suniti Mishra, Olivier Glehen in Indian Journal of Surgical Oncology

   Article 04 August 2022
   

8. Latissimus dorsi musculocutaneous flap grafting to the infected recipient site in a patient with irradiated locally advanced breast cancer and multiple lung metastases

   Background

   Musculocutaneous (MC) flaps are more resistant to infection than implants, but no clinical results have been reported so far about the...

   Yuki Ishii, Hitomi Matsuki, ... Shoji Oura in Surgical Case Reports

   Article Open access 10 July 2023
   

9. Current Management of Neuroendocrine Tumour Liver Metastases

   Purpose of review

   This article aims to illustrate the current state of investigations and management of liver metastases in patients with...

   Aditya Sharma, Mughilan Muralitharan, ... Rajaventhan Srirajaskanthan in Current Oncology Reports

   Article Open access 13 June 2024
   

10. An Update on the Management of Bone Metastases

    Purpose of Review

    Increasing life expectancy among patients with advanced cancer has placed a greater emphasis on optimizing pain control and quality...

    Alexander J. Grosinger, Sara R. Alcorn in Current Oncology Reports

    Article Open access 28 March 2024

11. A long-term survival case of bladder cancer with distant metastases: abscopal effect of brain metastases after stereotactic radiotherapy with immune checkpoint blockade therapy to lung metastases

    Brain metastases from bladder cancer are rare, with a poor prognosis. There is no standard treatment for bladder cancer with brain metastases; thus,...

    Sawa Kono, Yaichiro Hashimoto, ... Kumiko Karasawa in International Cancer Conference Journal

    Article 03 April 2023
    

12. Port-Site Metastases in Incidentally Detected Carcinoma Gall Bladder: Role of 18F-FDG PET/CT and Patient Outcome

    Background

    Incidentally detected gall bladder carcinoma (IGBC) is occasionally encountered after cholecystectomy for benign gall bladder disease....

    Vivek Kumar Saini, AftabNazar Hassan, ... Sanjay Gambhir in Journal of Gastrointestinal Cancer

    Article 24 January 2022
    

13. Ocular metastases profile in a tertiary hospital in São Paulo, Brazil

    Objective

    Ocular metastases are the most common intraocular tumours in adults. Data regarding the occurrence of these tumours in the Brazilian...

    Matheus Senna Pereira Ogata, Guilherme Rodrigues Ferreira, ... Arthur Gustavo Fernandes in International Journal of Retina and Vitreous

    Article Open access 16 April 2024
    

14. Unusual soft tissue metastases in a patient with chondrosarcoma: a case report

    Chondrosarcoma (CS) is the second most frequent primary malignant bone tumour, characterized by production of non‐osteoid cartilage matrix. Up to...

    Giuseppe Francesco Papalia, Sisith Ariyaratne, ... Vineet Kurisunkal in International Cancer Conference Journal

    Article 07 May 2024
    

15. Palliative Arterial Embolization for Metastases of the Sternum

    Background

    To investigate the safety and efficacy of palliative arterial embolization for metastases of the sternum.

    Materials and Methods ...

    Nicolas Papalexis, Giuliano Peta, ... Giancarlo Facchini in CardioVascular and Interventional Radiology

    Article 15 May 2023
    

16. Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer

    Purpose

    Programmed death receptor ligand-1 (PD-L1) expression and tumor mutational burden (TMB) are approved screening biomarkers for immune...

    Robert Hsu, Batul Al-zubeidy, ... Evanthia T. Roussos Torres in Breast Cancer Research and Treatment

    Article Open access 20 April 2024
    

17. Brain metastases of sarcoma: a rare phenomenon in rare tumours

    The usual site for distant metastases of sarcoma is lungs, while brain metastasis (BM) occurs much less frequently and usually late in the disease...

    Wiktoria Jędrys, Aleksandra Leśniak, ... Paweł Sobczuk in Journal of Cancer Research and Clinical Oncology

    Article Open access 23 November 2023

18. Incidence, Risk Factors, and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases

    Objective

    Brain metastases significantly impact the clinical course of patients with hepatocellular carcinoma (HCC). This study aimed to examine the...

    **-cheng Feng, Ying He, ... Jun **ong in Current Medical Science

    Article 23 February 2024

19. Clinical benefits of pulmonary resection for lung metastases from pancreatic cancer

    Purpose

    Systemic chemotherapy is generally used for metastatic pancreatic cancer; however, pulmonary resection may be a treatment option for lung...

    Takanori Konishi, Shigetsugu Takano, ... Masayuki Ohtsuka in Langenbeck's Archives of Surgery

    Article 18 December 2023
    

20. Evolution of structural rearrangements in prostate cancer intracranial metastases

    Intracranial metastases in prostate cancer are uncommon but clinically aggressive. A detailed molecular characterization of prostate cancer...

    Francesca Khani, William F. Hooper, ... Himisha Beltran in npj Precision Oncology

    Article Open access 13 September 2023